ChromaDex Corporation (CDXC) Social Stream
ChromaDex Corp (CDXC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CDXC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CDXC's average price target has moved up $3.55 over the prior 22 months.
Over the past 49 weeks, CDXC's average upside potential has been 135.1%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CDXC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CDXC's average broker recommendation rating improved by 0 over the prior 59 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDXC as an investment opportunity.
- ChromaDex Corp's upside potential (average analyst target price relative to current price) is higher than 379.42% of all US stocks.
- CDXC has a higher average analyst price target than 52.56% of all US stocks.
- ChromaDex Corp's variance in analysts' estimates is lower than -100.31% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, ChromaDex Corp's number of analysts covering the stock is higher than 133.4% of them.
What is the outlook for CDXC? Use POWR Ratings for clearer insight into price direction.